Kenneth W. O'Keefe - 07 Aug 2025 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
Director
Signature
By: /s/Adam Guttmann, as attorney in fact For: Kenneth O'Keefe
Issuer symbol
JAZZ
Transactions as of
07 Aug 2025
Net transactions value
-$200,807
Form type
4
Filing time
11 Aug 2025, 17:55:53 UTC
Previous filing
06 Aug 2024
Next filing
04 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
O'Keefe Kenneth W Director 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND By: /s/Adam Guttmann, as attorney in fact For: Kenneth O'Keefe 11 Aug 2025 0001397661

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Award $0 +3,507 +13% $0.000000 30,477 07 Aug 2025 Direct F1
transaction JAZZ Ordinary Shares Tax liability $200,807 -1,805 -5.9% $111.25 28,672 08 Aug 2025 Direct F2
holding JAZZ Ordinary Shares 4,445 07 Aug 2025 by Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 24, 2026.
F2 Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F3 Shares are held for the benefit of The Kenneth W. O'Keefe Trust U/A/D 2/12/1997, of which the reporting person is both trustee and beneficiary.